Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Clinical Trials in China / NCT04295473
Recruiting Not applicable

Reduced Port Laparoscopic Gastrectomy for Gastric Cancer

NCT04295473 · tracked via the Priya Life Science China tracker
Sponsor
Nanchong Central Hospital
Phase
Not applicable
Started
2020-03-02
Last updated
2025-05-21

Condition(s) studied

LaparoscopicGastrectomy

Investigational drug(s) / intervention(s)

Reduced port laparoscopic gastrectomy

Reduced port laparoscopic gastrectomy: The ports were reduced in the surgery of intervention arm.

Study summary

Reduced port laparoscopic gastrectomy has been adopted in clinical. The safety and outcome of reduced port laparoscopic gastrectomy has not been systematically evaluated. The investigators sought to compare the short and long-term outcome of patients with gastric cancer who underwent reduced port gastrectomy with patients underwent traditional laparoscopic gastrectomy

Eligibility

Sex
ALL
Min age
18 Years
Max age
90 Years
Healthy volunteers
No
Inclusion Criteria: 1. Histologically confirmed adenocarcinoma of the stomach, T1-T4 stages. 2. Eastern Cooperative Oncology Group performance status of 0 or 1. 3. Adequate organ function. Exclusion Criteria: 1. Patients had distant metastasis. 2. oesophageal invasion of more than 3 cm. 3. Borrmann type 4 or large (more than 8 cm) type 3 carcinoma. 4. Previous chemotherapy or radiation therapy for any other malignancies.

Primary outcome measure(s)

  • 5-year survival rate — 5 years
    Longterm survival for patients with gastrectomy after reduced port laparoscopic gastrectomy
  • 3-year survival rate — 3 years
    Survival rate for patients with gastrectomy after reduced port laparoscopic gastrectomy

Trial sites (1)

FacilityCityRegionStatus
Yunhong Tian Nanchong Sichuan Recruiting

More Nanchong Central Hospital trials in China

The Impact of 3D Patch One-Suture Fixation vs No Fixation on Chronic Pain and Recurrence in Ⅲ Inguinal Hernia Enrolling by invitation
Uterine Round Ligament Preservation Vs Resection in Laparoscopic Inguinal Hernia Repair in Women：A Multicenter,Stratified Randomized Controlled Trial Recruiting
Stapler Reinforcement Patches Compared to Standard Staplers in Gastrojejunostomy Recruiting
Treatment of Post-Stroke Central Pain Recruiting
Oral Lactulose for Gastrointestinal Recovery After Complex Appendectomy Recruiting

Other trials for the same condition

Efficacy and Safety of Anrikefon Injection for the Treatment of Postoperative Pain in Patients Undergoing Totally Laparoscopic Radical Distal Gastrectomy Recruiting
The Influence of Splenic Artery Characteristics in Gastric Cancer Surgery Active, not recruiting
Comparing Laparoscopic and Open Surgery for Pancreatic Carcinoma Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04295473 on ClinicalTrials.gov ↗ ← All trials in China